Pages that link to "Q37322109"

The following pages link to Prevalence and definition of drooling in Parkinson's disease: a systematic review (Q37322109):

Displaying 27 items.

• Salivary Secretory Disorders, Inducing Drugs, and Clinical Management (Q26777907) (← links)
• Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat (Q26825102) (← links)
• Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes (Q28082795) (← links)
• The management of gastrointestinal symptoms in Parkinson’s disease (Q34250597) (← links)
• Diurnal and nocturnal drooling in Parkinson's disease (Q35653537) (← links)
• Parkinson's disease between internal medicine and neurology (Q36464243) (← links)
• Gene therapy: a viable therapeutic strategy for Parkinson's disease? (Q37801855) (← links)
• Nonmotor Disturbances in Parkinson’s Disease (Q37825377) (← links)
• Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management (Q37889470) (← links)
• Pathological correlates of gastrointestinal dysfunction in Parkinson's disease (Q37952056) (← links)
• Swallowing in Parkinson's disease: clinical issues and management (Q39385695) (← links)
• Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia. (Q39404897) (← links)
• A new definition of dental sleep medicine. (Q47830669) (← links)
• Impact of cognitive dysfunction on drooling in Parkinson's disease (Q50250125) (← links)
• Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild (Q50267171) (← links)
• The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders (Q51112226) (← links)
• Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. (Q52672547) (← links)
• Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience. (Q55483517) (← links)
• SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. (Q64770162) (← links)
• Pathophysiology of diurnal drooling in Parkinson's disease (Q83836563) (← links)
• Reproducibility and Validity of Patient-Rated Assessment of Speech, Swallowing, and Saliva Control in Parkinson's Disease (Q84445481) (← links)
• Hypersialorrhea in Wilson's Disease (Q85649169) (← links)
• Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management (Q89912027) (← links)
• The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) (Q91831435) (← links)
• Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial (Q92595903) (← links)
• Botulinum toxin for drooling in Parkinson’s disease (Q94322481) (← links)
• Parkinson disease and the gut: new insights into pathogenesis and clinical relevance (Q98184349) (← links)